Volume 15, issue 12, December 2010

8 articles in this issue

Multiresistant bacteria and current therapy - the economical side of the story

Authors
- MH Wilke
- Content type: Research
- Published: 30 November 2010
- Article: 571
Pharmaco-economic evaluation of antibiotic therapy strategies in DRG-based healthcare systems - a new approach

Authors
- MH Wilke
- R Grube
- Content type: Research
- Published: 30 November 2010
- Article: 564
Treatment of complicated skin and soft-tissue infections caused by resistant bacteria: value of linezolid, tigecycline, daptomycin and vancomycin

Authors
- Christian Eckmann
- Matthew Dryden
- Content type: Review
- Published: 30 November 2010
- Article: 554
Complicated skin, skin structure and soft tissue infections - are we threatened by multi-resistant pathogens?

Authors
- P Kujath
- C Kujath
- Content type: Review
- Published: 30 November 2010
- Article: 544
Comparison of the pharmacokinetic properties of vancomycin, linezolid, tigecyclin, and daptomycin

Authors
- Kerry S Estes
- Hartmut Derendorf
- Content type: Review
- Published: 30 November 2010
- Article: 533
Treatment of complicated intra-abdominal infections in the era of multi-drug resistant bacteria

Authors
- T Herzog
- AM Chromik
- W Uhl
- Content type: Review
- Published: 30 November 2010
- Article: 525
Nosocomial methicillin resistant Staphylococcus aureus pneumonia - epidemiology and trends based on data of a network of 586 German ICUs (2005-2009)

Authors
- Elisabeth Meyer
- Frank Schwab
- Petra Gastmeier
- Content type: Review
- Published: 30 November 2010
- Article: 514
Nosocomial methicillin-resistant staphylococcus aureus (MRSA) pneumonia: linezolid or vancomycin? - Comparison of pharmacology and clinical efficacy

Authors
- Mathias W Pletz
- Olaf Burkhardt
- Tobias Welte
- Content type: Review
- Published: 30 November 2010
- Article: 507